Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
128.66 | -8.69% | 4.69% | 327,466.53 | 2.38% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
122.46 | 16.88% | 39.22% | 190,957.95 | 2% | 15.98% |
|
SWX:NOVN
Novartis
|
93.49 | 8.5% | 21.92% | 189,900.62 | 3.55% | 4.67% |
|
SWX:ROG
Roche Holding
|
224.60 | 30.46% | 46.37% | 183,894.9 | 4.21% | 0.43% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 14.77% | 33.02% | 115,761.94 | 4.06% | 8.19% |
|
LSE:GSK
GSK
|
18.10 | 5.36% | 20.88% | 73,812.48 | 3.2% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.71 | 58.04% | 68.14% | 91,341.13 | 5.33% | 13.54% |
|
ENXTPA:IPN
Ipsen
|
121.40 | -14.58% | -6.56% | 9,878.9 | 1.01% | 9.14% |
|
ENXTBR:SOLB
Solvay
|
34.52 | 17.96% | 41.12% | 3,611.22 | 7.08% | 9.75% |
|
NSEI:PFIZER
Pfizer
|
4327.45 | 14.48% | 21.43% | 194,757.24 | 0.8% | 10.3% |
|
HOSE:DHG
DHG Pharmaceutical Joint Stock
|
116600.00 | 24.25% | 39.02% | 14,918,126.7 | 3% | 0% |
|
ASX:MYX
Mayne Pharma Group
|
6.66 | -,102.84% | -,101.6% | 565.6 | 0% | 0% |
|
UNQ-VNM:PME
Pymepharco Joint Stock
|
80200.00 | -7.78% | 12.99% | 6,015,932.33 | 2.49% | -0.94% |
|
HOSE:DBD
Binh Dinh Pharmaceutical and Medical
Equipment Joint Stock |
52700.00 | 31.14% | 0% | 3,974,188.47 | 3.8% | 21.39% |
|
HOSE:TRA
Traphaco Joint Stock
|
82400.00 | 66.6% | 0% | 3,382,364.06 | 3.77% | -4.9% |
|
HOSE:DCL
Cuu Long Pharmaceutical Joint Stock
|
29950.00 | 0% | 0% | 1,972,107.81 | 0% | 0% |
|
HOSE:DMC
Domesco Medical Import - Export
Joint-Stock |
56200.00 | 0% | 0% | 1,739,846 | 4.2% | 7.48% |
|
HOSE:OPC
OPC Pharmaceutical Joint Stock
|
23950.00 | 0% | 0% | 1,614,082.48 | 6.3% | 0% |
|
HNX:LDP
Lamdong Pharmaceutical Joint Stock
|
22300.00 | 0% | 0% | 284,550.22 | 0% | 0% |
|
HOSE:DBT
Ben Tre Pharmaceutical Joint Stock
|
12700.00 | 0% | 0% | 207,333.56 | 0% | 0% |
